Chiusura precedente | 10,33 |
Aperto | 10,36 |
Denaro | 10,33 x 39400 |
Lettera | 10,36 x 1000 |
Min-Max giorno | 10,36 - 10,36 |
Intervallo di 52 settimane | 9,84 - 10,70 |
Volume | |
Media Volume | 68.640 |
Capitalizzazione | 163,817M |
Beta (5 anni mensile) | N/D |
Rapporto PE (ttm) | N/D |
EPS (ttm) | N/D |
Prossima data utili | N/D |
Rendimento e dividendo (forward) | N/D (N/D) |
Data ex dividendo | N/D |
Stima target 1A | N/D |
BRANFORD, Conn., Aug. 23, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (Nasdaq: ISO) (“IsoPlexis”), a company empowering labs to leverage the cells and proteome changing the course of human health, today announced the appointment of Nachum “Homi” Shamir to its Board of Directors as a Class II director. Mr. Shamir was most recently the Chairman and Chief Executive Officer of Luminex Corporation from 2014 through its sale to DiaSorin S.p.A. in 2021. Additionally, Mr. Shamir has served as Preside
CRANBURY, NJ, April 05, 2022 (GLOBE NEWSWIRE) -- Cactus Acquisition Corp. 1 Limited (NasdaqGM: CCTS, CCTSU and CCTSW) (the “Company”) announced today that it filed its annual report on Form 10-K for the year ended December 31, 2021 with the Securities and Exchange Commission on March 31, 2022. Copies of the annual report and other filings are available online through the Company’s website, https://cactusac1.com/, or by accessing the Securities and Exchange Commission’s website, www.sec.gov. Copi